Search

Former college lacrosse player Mikaela Rix, diagnosed at age 26, accessed a wide range of resources offered by MSK’s new program tailored for young women with breast cancer.

… Monday, October 4, 2021 At first, Mikaela Rix was not worried about the tiny lump in her breast. It felt like a frozen pea, and she assumed it was a benign cyst. A former Boston College lacrosse player, 26-year-old Mikaela assumed she was in perfect health. She became uneasy when the radiologist looked

Thousands of technology professionals from around the world recently gathered in Long Beach, California, for the sold-out Neural Information Processing Systems (NIPS) conference, a multi-track machine learning, artificial intelligence, and computational neuroscience event featuring talks, demonstrations, symposia and oral / poster presentations, along with several workshops. Leaders in artificial intelligence, machine learning, and data engineering from Memorial Sloan Kettering attended NIPS and announced the winner of a unique competition created by MSK, Classifying Clinically Actionable Genetic Mutations. For more information and to set up interviews or access photos and video, email [email protected].

… Monday, December 11, 2017 Thousands of technology professionals from around the world recently gathered in Long Beach, California, for the sold-out Neural Information Processing Systems (NIPS) conference, a multi-track machine learning, artificial intelligence, and computational neuroscience event featuring

MSK experts co-authored a piece in Targeted Oncology about the findings from a recent clinical trial.

… Tuesday, May 11, 2021 MSK radiation oncologists Kaveh Zakeri, Yao Yu , and Nancy Lee co-authored an article published on May 6 in Targeted Oncology that discusses a recent study led by Dr. Lee. The study , published in April in the journal Lancet Oncology , found that the addition of immunotherapy to

Three winners of the first-ever Breakthrough Prizes — Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center; Cornelia I. Bargmann, PhD, of the Rockefeller University; and Lewis C. Cantley, PhD, of Weill Cornell Medical College — have committed a portion of their Breakthrough Prize in Life Sciences award to establish a new annual prize for promising postdoctoral trainees.

… Monday, May 12, 2014 New Annual Life Sciences Award for Postdoctoral Trainees Established Following last year’s announcement of the first-ever Breakthrough Prizes, established by a well-known group of Silicon Valley entrepreneurs to celebrate scientists and encourage careers in the field, the winners

SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight.

… Wednesday, July 29, 2020 SKI Director, Joan Massagué, PhD , is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis, the cause of 90 percent of cancer deaths. He is featured in the July 29 MSK Science Spotlight . Dr. Massagué studies the control of stem

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.

… Wednesday, July 1, 2009 Summary A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer. A team of researchers led by Memorial Sloan

It's not only what's inside your cells that determines your cancer risk. It's what surrounds them too.

… Tuesday, June 26, 2018 Summary Scientists are learning that inflammation can play a role in cancer development. This is one example of how the environment surrounding an abnormal cell can influence its fate. Growing up, Philipp Niethammer learned from his mother to never scratch his moles. “I am not

Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center and other centers within The Cancer Genome Atlas Research Network.

… Wednesday, May 1, 2013 Endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials, according to a large-scale genomic analysis led by researchers at Memorial Sloan Kettering Cancer Center

Learn how Danielle has faced hereditary breast cancer caused by a BRCA1 gene mutation and had fewer side effects than traditional chemotherapy because of an experimental treatment at MSK.

… Thursday, October 5, 2023 In March 2023, Danielle Polumbo found a lump in her breast. “It shook me to my core,” the 28-year-old remembers. “I knew right away that this was not good.” Just 18 months earlier, Danielle had learned that she carried a mutation in the BRCA1 gene , which greatly increases risk

Learn more about how the keto diet may one day be used as a boost to cancer treatment.

… Tuesday, May 11, 2021 The ketogenic, or “keto,” diet may have benefits beyond a whittled waistline. The low-carbohydrate, high-fat diet that helps your body to use fat as fuel may also be beneficial in the fight against cancer. Memorial Sloan Kettering medical oncologist Vicky Makker is studying the